STOCK TITAN

Aramark CFO exercises 8,852 stock options

Aramark’s EVP and CFO exercised stock options nearing expiration, with shares withheld to cover the exercise price and taxes.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Aramark (ARMK) reports that EVP and CFO James J. Tarangelo exercised stock options for 8,852 shares of Common Stock on September 3, 2026 at an exercise price of $24.58 per share. In connection with this fully vested option, 6,048 shares of Common Stock were delivered or withheld to satisfy the payment of the exercise price and tax withholding obligations. These options were scheduled to expire on November 18, 2026, and no Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.
Insider Tarangelo James J.
Role EVP and CFO
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F2 8,852 $0.00 $0.00
Exercise Common Stock 8,852 $24.58 $218K
Exercise Price or Tax Liability Common Stock F1 6,048 $56.81 $344K
Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 63,172.536 shares (Direct)
Footnotes (2)
  1. F1. Represents a net exercise of a stock option expiring on November 18, 2026, in which shares of Common Stock were disposed to satisfy the payment of the exercise price and tax withholding obligations.
  2. F2. These options are fully vested and were scheduled to expire on November 18, 2026.
Options exercised 8,852 shares Stock options converted into Common Stock on September 3, 2026
Option exercise price $24.58 per share Exercise price for 8,852 stock options
Shares delivered/withheld 6,048 shares Shares of Common Stock delivered or withheld to pay exercise price and tax withholding
Share value used for tax/exercise $56.81 per share Per-share value applied to 6,048 shares for payment of exercise price or tax liability
Option expiration date November 18, 2026 Scheduled expiration date of the exercised options
Derivative exercises reported 1 transaction Exercise or conversion of derivative security in this Form 4
Transactions for exercise-price or tax liability 1 transaction, 6,048 shares Code F disposition to cover exercise price or tax withholding
Stock Option (Right to Buy) financial
"The security title is reported as Stock Option (Right to Buy)"
net exercise financial
"Represents a net exercise of a stock option expiring on November 18, 2026"
A net exercise is a way to convert stock options into shares without paying cash up front: instead of handing over money to buy the optioned shares, the holder receives only the number of shares equal to the option’s value after the company withholds a portion of shares to cover the exercise price and taxes. It matters to investors because it changes how many new shares are issued, affects dilution of existing shareholders, and alters company cash flow compared with a cash exercise.
tax withholding obligations financial
"shares of Common Stock were disposed to satisfy the payment of the exercise price and tax withholding obligations"
Payment of exercise price or tax liability financial
"Payment of exercise price or tax liability by delivering or withholding securities"

FAQ

What did Aramark (ARMK) EVP and CFO James J. Tarangelo report in this Form 4?

He reported exercising 8,852 stock options for Aramark Common Stock on September 3, 2026, at an exercise price of $24.58 per share, with a portion of the resulting shares delivered or withheld to cover the exercise price and tax withholding obligations.

How many Aramark (ARMK) stock options did the CFO exercise and at what price?

The CFO exercised 8,852 stock options for Aramark Common Stock at an exercise price of $24.58 per share. The filing notes that these options were fully vested and scheduled to expire on November 18, 2026.

How many Aramark (ARMK) shares were used to pay exercise price and taxes?

A total of 6,048 shares of Aramark Common Stock were delivered or withheld on September 3, 2026 to satisfy the payment of the option exercise price and tax withholding obligations, according to the Form 4 footnote.

Were the Aramark (ARMK) CFO’s option exercises done under a Rule 10b5-1 plan?

No. The Form 4 indicates that no Rule 10b5-1 trading plan is reported for these transactions, meaning the filing does not state that they were executed under a pre-arranged trading plan.

When were the Aramark (ARMK) stock options scheduled to expire?

The stock options exercised by the CFO were fully vested and were scheduled to expire on November 18, 2026, as disclosed in the Form 4 footnote.

What types of securities are involved in this Aramark (ARMK) Form 4?

The Form 4 involves a Stock Option (Right to Buy) derivative security that converted into 8,852 shares of Aramark Common Stock, and related dispositions of 6,048 shares of Common Stock to cover the exercise price and tax withholding obligations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tarangelo James J.

(Last)(First)(Middle)
2400 MARKET STREET

(Street)
PHILADELPHIA PENNSYLVANIA 19103

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP and CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/03/2026M8,852A$24.5869,220.536D
Common Stock09/03/2026F6,048D$56.81(1)63,172.536D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$24.5809/03/2026M8,852 (2)11/18/2026Common Stock8,852$00D
Explanation of Responses:
1. Represents a net exercise of a stock option expiring on November 18, 2026, in which shares of Common Stock were disposed to satisfy the payment of the exercise price and tax withholding obligations.
2. These options are fully vested and were scheduled to expire on November 18, 2026.
Remarks:
/s/ Ryan S. Spengler, as Attorney-in-fact09/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading